SCHEMBL2433586

SCHEMBL2433586

CC(C)NC(=O)C(C)(CCC(F)(F)C(F)(F)F)S(=O)(=O)CCC(F)(F)F

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.31
CNR2 P34972 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2431485 0.84 CNR1 (0.30) CNR1CNR2
SCHEMBL2426053 0.82
SCHEMBL2427566 0.81
SCHEMBL2429626 0.80 EPHX1 (0.33)
SCHEMBL2432046 0.79
SCHEMBL2434721 0.78
SCHEMBL12287366 0.75
SCHEMBL2434827 0.74
SCHEMBL2433906 0.73 CYP4F2 (0.33)
SCHEMBL2426037 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8017656-B2 Organic sulfur compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-09-13 US disclosed
US-8017656-B2 Organic sulfur compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-09-13 US disclosed
US-20090186941-A1 ORGANIC SULFUR COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-23 US disclosed
US-20090186941-A1 ORGANIC SULFUR COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-23 US disclosed
EP-1951664-A1 ORGANIC SULFUR COMPOUNDS AND USE THEREOF AS ARTHROPODICIDES Sumitomo Chemical Company, Limited (JP) 2008-08-06 EP disclosed
WO-2007060839-A1 ORGANIC SULFUR COMPOUNDS AND USE THEREOF AS ARTHROPODICIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-05-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090186941-A1 ORGANIC SULFUR COMPOUNDS AND USE THEREOF TST, SQOR, TRPA1 CNR1 1910/4885CNR2 1875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.